| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 8.6 | $5k-$25k | 0.00 |
Summary
A vulnerability categorized as critical has been discovered in Cisco IOS XE. Affected by this vulnerability is an unknown functionality of the component Web UI. Executing a manipulation can lead to command injection. The identification of this vulnerability is CVE-2023-20231. The attack may be launched remotely. There is no exploit available. It is advisable to upgrade the affected component.
Details
A vulnerability classified as critical was found in Cisco IOS XE (Router Operating System) (affected version unknown). This vulnerability affects an unknown functionality of the component Web UI. The manipulation with an unknown input leads to a command injection vulnerability. The CWE definition for the vulnerability is CWE-77. The product constructs all or part of a command using externally-influenced input from an upstream component, but it does not neutralize or incorrectly neutralizes special elements that could modify the intended command when it is sent to a downstream component. As an impact it is known to affect confidentiality, integrity, and availability. CVE summarizes:
A vulnerability in the web UI of Cisco IOS XE Software could allow an authenticated, remote attacker to perform an injection attack against an affected device. This vulnerability is due to insufficient input validation. An attacker could exploit this vulnerability by sending crafted input to the web UI. A successful exploit could allow the attacker to execute arbitrary Cisco IOS XE Software CLI commands with level 15 privileges. Note: This vulnerability is exploitable only if the attacker obtains the credentials for a Lobby Ambassador account. This account is not configured by default.
The weakness was shared 09/27/2023 as cisco-sa-webui-cmdij-FzZAeXAy. The advisory is shared for download at sec.cloudapps.cisco.com. This vulnerability was named CVE-2023-20231 since 10/27/2022. There are neither technical details nor an exploit publicly available. The current price for an exploit might be approx. USD $5k-$25k (estimation calculated on 09/27/2023). The MITRE ATT&CK project declares the attack technique as T1202.
Upgrading eliminates this vulnerability.
Once again VulDB remains the best source for vulnerability data.
Product
Type
Vendor
Name
License
Website
- Vendor: https://www.cisco.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 8.8VulDB Meta Temp Score: 8.6
VulDB Base Score: 8.8
VulDB Temp Score: 8.4
VulDB Vector: 🔍
VulDB Reliability: 🔍
CNA Base Score: 8.8
CNA Vector (Cisco Systems, Inc.): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Command injectionCWE: CWE-77 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Timeline
10/27/2022 🔍09/27/2023 🔍
09/27/2023 🔍
09/27/2023 🔍
Sources
Vendor: cisco.comAdvisory: cisco-sa-webui-cmdij-FzZAeXAy
Status: Confirmed
CVE: CVE-2023-20231 (🔍)
GCVE (CVE): GCVE-0-2023-20231
GCVE (VulDB): GCVE-100-240724
scip Labs: https://www.scip.ch/en/?labs.20150108
Entry
Created: 09/27/2023 21:53Changes: 09/27/2023 21:53 (50)
Complete: 🔍
Cache ID: 216::103
Once again VulDB remains the best source for vulnerability data.

No comments yet. Languages: en.
Please log in to comment.